ACR Basic and Clinical Research Conference: Rheumatologic Complications of Emerging Viral Infections / SARS-CoV-2

ACR 基础与临床研究会议：新发病毒感染的风湿病并发症 / SARS-CoV-2

• 批准号: 10318355
• 负责人: Kristine A. Kuhn
• 金额: $ 5.4万
• 依托单位: AMERICAN COLLEGE OF RHEUMATOLOGY
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-08-10 至 2022-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10318355
• 关键词: 2019-nCoV; Advocacy; Affect; Alabama; American; Antiphospholipid Antibodies; Arthritis; Autoantibodies; Basic Science; Biological Response Modifier Therapy; COVID-19; COVID-19 vaccine; Caring; Child; Childhood; Clinical; Clinical Research; Clinical Services; Colorado; Communities; Complement; Data; Dermatologic; Development; Diagnosis; Discipline; Disease; Education; Event; Fellowship Program; Fostering; Foundations; Functional disorder; Goals; Health; Health Services Research; Healthcare; Human; Immunocompromised Host; Individual; Interferons; Investigation; Knowledge; Medical; Medical Research; Medicine; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Participant; Patient Care; Patients; Pattern; Pediatrics; Play; Practice Management; Public Health; Research; Research Personnel; Research Training; Resources; Rheumatism; Rheumatology; Role; SARS-CoV-2 infection; Schedule; Scientist; Site; Syndrome; Time; Training; Translating; Translational Research; Underrepresented Minority; United States National Institutes of Health; Universities; Viral; Virus; Virus Diseases; base; clinical decision-making; college; comorbidity; cost; cytokine; cytokine release syndrome; improved; interest; meetings; mid-career faculty; neutrophil; novel therapeutics; pandemic disease; professor; rheumatologist; severe COVID-19; symposium; systemic autoimmunity; virtual

Project Summary-Abstract The American College of Rheumatology (ACR) has been a leader in the effort to facilitate the bidirectional exchange of cutting-edge scientific information between scientists and investigators in rheumatic diseases through its annual Basic and Clinical Research Conferences. Historically, these scientific symposia have occurred immediately prior to the ACR annual meeting at the site of the meeting. This past year, based on the pandemic restrictions, these symposia were hosted virtually as a post-event to the annual meeting. The ACR annual meeting, ACR Convergence, attracts more than 15,000 attendees each year and is the principal mechanism for providing a forum for the exchange of ideas about research, education, patient care, practice management and advocacy issues. Because the Basic and Clinical Research Conferences are pre- meeting events for ACR Convergence, ACR has been able to attract renown scientists and investigators who may otherwise not have attended. For 2021, the Basic and Clinical Research Conferences will be held jointly to attract scientists and investigators from both the basic, clinical and translational research communities. The title of the conference will be Rheumatologic Complications of Emerging Viral Infections / SARS-CoV-2. This combined approach will focus on emerging viral infections, especially as they relate to SARS-CoV-2. This deadly global pandemic has provided an enormous influx of data relevant to rheumatologists. Not only is the rheumatologist confronted with managing her/his own patients with rheumatic diseases on various anti-rheumatic therapies, but viruses like SARS-CoV-2 are responsible for triggering rheumatologic complications among a substantial number of infected individuals. Rheumatologists have an important role to play in diagnosing and treating these complications. Moreover, rheumatologists have expertise in many of the biologic therapeutics being employed to treat severe SARS-CoV-2 infections. Ever expanding knowledge from viral pandemics is important to share with rheumatologists who are integral to the care of infected individuals worldwide. Clinical research sessions will focus on topics such as the impact of COVID-19 vaccines for immunocompromised hosts, cytokine storm syndrome, and dermatologic manifestations of COVID-19. Basic research sessions will explore topics such as auto-antibodies to type 1 interferon and other cytokines, anti- phospholipid antibodies and their role in comorbidities, and neutrophil dysregulation and NETs in COVID-19. The conference organizers include Dr. Randy Cron, Professor of Pediatrics and Medicine at the University of Alabama at Birmingham (UAB) and the Arthritis Foundation, Alabama chapter endowed chair in Pediatric Rheumatology. Dr. Cron is the Director of the Division of Pediatric Rheumatology and the Pediatric Rheumatology Fellowship Program at Children's of Alabama; Dr. Mariana Kaplan, NIAMS Chief of the Systemic Autoimmunity Branch. She is also Deputy Scientific Director at NIAMS; and ACR Committee on Research (Dr. Kristine Kuhn, Chair). The ACR Committee on Research focuses on research and research training in rheumatology and encourages clinical and health services research on the organization of medical and health care as they may affect patients with rheumatic diseases. Dr. Kuhn, Chair, is Associate Professor, Medicine-Rheumatology at the University of Colorado Anschutz Medical Campus.

项目摘要提取 美国风湿病学院（ACR）一直是促进双向的领导者 风湿性疾病中的科学家与研究人员之间的尖端科学信息交流 通过其年度基本和临床研究会议。从历史上看，这些科学专题讨论会 发生在会议场地的ACR年会之前就发生。过去的一年，根据 大流行限制，这些专题讨论会实际上是在年度会议后举办的。 ACR年度会议ACR融合，每年吸引15,000多名与会者，是 提供有关研究，教育，患者护理的想法的论坛的主要机制， 实践管理和倡导问题。因为基本和临床研究会议是前 会议活动的ACR融合活动，ACR能够吸引著名的科学家和调查人员 否则可能没有参加。 2021年，将共同举行基础和临床研究会议，以吸引科学家和研究人员 来自基本，临床和转化研究社区。会议的标题将是 新兴病毒感染 / SARS-COV-2的风湿病并发症。这种组合的方法将集中 关于新兴的病毒感染，尤其是与SARS-COV-2相关时。这个致命的全球大流行有 提供了大量与风湿病学家有关的数据。风湿病学家不仅面临 在各种抗风湿性疗法上管理自己患有风湿病的患者，但病毒像 SARS-COV-2负责触发大量数量的风湿病并发症 受感染的人。风湿病学家在诊断和治疗这些方面起着重要的作用 并发症。此外，风湿病学家在许多生物治疗剂中都有专业知识 治疗严重的SARS-COV-2感染。从病毒大流行病中扩展知识很重要 与风湿病学家在一起，这些医生是全球受感染者的护理不可或缺的一部分。 临床研究课程将集中于诸如Covid-19疫苗对 COVID-19的免疫功能低下宿主，细胞因子风暴综合征和皮肤病表现。基本的 研究课程将探索诸如1型干扰素和其他细胞因子的自动抗体等主题 磷脂抗体及其在合并症中的作用，嗜中性粒细胞失调和网络中的网络中的网络。 会议组织者包括大学儿科和医学教授Randy Cron博士 伯明翰（UAB）和关节炎基金会的阿拉巴马州，阿拉巴马州分会恩德·科特里奇 风湿病。 Cron博士是小儿风湿病学和小儿的主任 阿拉巴马州儿童的风湿病学奖学金计划；尼亚姆斯（Niams）主任玛丽安娜·卡普兰（Mariana Kaplan）博士 系统性自身免疫分支。她还是Niams的副科学总监；和ACR委员会 研究（Kristine Kuhn博士，主席）。 ACR研究委员会的重点是研究和研究 风湿病学培训并鼓励有关医疗组织的临床和健康服务研究 和医疗保健可能会影响风湿病患者。 Kuhn博士是副教授， 科罗拉多大学Anschutz大学医学校园的医学 - 鲁姆病学。